SYNLOGIC, INC. (SYBX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US87166L1008
Price
1.10 USD
Market cap
13.54 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–
SYNLOGIC, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 0.00 USD |
| Operating income | -4.01 m USD |
| EBIT | -1.01 m USD |
| Net income | -1.01 m USD |
| Diluted EPS – continuing operations | -0.08 USD |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About SYNLOGIC, INC.
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.
More stocks
- KEEMO Fashion Group Ltd (KMFG)
- MDxHealth SA (MDXH)
- Virtuix Holdings Inc. (VTIX)
- Good Times Restaurants Inc. (GTIM)
- Linkhome Holdings Inc. (LHAI)
- Foreveren (FOR.WA)
- Greenpro Capital Corp. (GRNQ)
- CENTURY CASINOS INC /CO/ (CNTY)
- Passage BIO, Inc. (PASG)
- AMERICAN BATTERY MATERIALS, INC. (BLTH)
- eHealth, Inc. (EHTH)
- Super League Enterprise, Inc. (SLE)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.